Search Result

Results for "

sterol synthesis

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5 alpha Reductase (1) Akt (3) Antibiotic (2) Autophagy (6) Biochemical Assay Reagents (1) Cytochrome P450 (4) Dihydrofolate reductase (DHFR) (1) Drug Intermediate (3) Drug Metabolite (1) Endogenous Metabolite (4) Environmental Pollutants (2) ERK (2) Ferroptosis (3) Fungal (7) FXR (1) HMG-CoA Reductase (HMGCR) (9) Isotope-Labeled Compounds (5) MDM-2/p53 (2) MMP (1) NF-κB (1) Parasite (1) Potassium Channel (1) Reference Standards (3) Src (2) Toll-like Receptor (TLR) (2)
By Research Areas:	Cancer (6) Cardiovascular Disease (7) Endocrinology (2) Infection (9) Inflammation/Immunology (3) Metabolic Disease (8)

By Targets:

5 alpha Reductase (1)

Akt (3)

Antibiotic (2)

Autophagy (6)

Biochemical Assay Reagents (1)

Cytochrome P450 (4)

Dihydrofolate reductase (DHFR) (1)

Drug Intermediate (3)

Drug Metabolite (1)

Endogenous Metabolite (4)

Environmental Pollutants (2)

ERK (2)

Ferroptosis (3)

Fungal (7)

FXR (1)

HMG-CoA Reductase (HMGCR) (9)

Isotope-Labeled Compounds (5)

MDM-2/p53 (2)

MMP (1)

NF-κB (1)

Parasite (1)

Potassium Channel (1)

Reference Standards (3)

Src (2)

Toll-like Receptor (TLR) (2)

By Research Areas:

Cancer (6)

Cardiovascular Disease (7)

Endocrinology (2)

Infection (9)

Inflammation/Immunology (3)

Metabolic Disease (8)

Inhibitors & Agonists

Natural
Products

Isotope-Labeled Compounds

Targets Recommended: DNA/RNA Synthesis

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0165A

Pravastatin sodium Maximum Cited Publications 8 Publications Verification CS-514 sodium	HMG-CoA Reductase (HMGCR) Autophagy Ferroptosis	Cardiovascular Disease Cancer
Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM.

HY-N7264

7α-Hydroxycholesterol 3 Publications Verification	HMG-CoA Reductase (HMGCR) Toll-like Receptor (TLR) Akt Src ERK MDM-2/p53	Metabolic Disease Inflammation/Immunology
7α-Hydroxycholesterol is a cholesterol oxide and can serve as a biomarker for oxidative stress and lipid peroxidation. 7α-Hydroxycholesterol has cytotoxic and pro-inflammatory activities. 7α-Hydroxycholesterol can also inhibit sterol synthesis and reduce the activity of HMG-CoA reductase. 7α-Hydroxycholesterol can be used in the research of diseases such as diabetes and atherosclerosis .

HY-17396

Butenafine Hydrochloride 1 Publications Verification KP363 Hydrochloride	Fungal Antibiotic	Infection
Butenafine Hydrochloride (KP363 Hydrochloride) is a synthetic benzylamine antifungal, works by inhibiting the synthesis of sterols by inhibiting squalene epoxidase.

HY-114296

2,3-Oxidosqualene Squalene oxide	Drug Intermediate Endogenous Metabolite	Others
2,3-Oxidosqualene (Squalene oxide) is a sterol biosynthesis precursor intermediate.2,3-Oxidosqualene participates in cyclization pathways that form sterols and triterpenes, and contributes to introduction of their characteristic 3-hydroxyl group.2,3-Oxidosqualene forms metabolically from squalene in rat liver homogenates under sterol synthesis conditions.2,3-Oxidosqualene converts to sterols including cholesterol, lathosterol, and lanost-8-en-3β-ol in rat liver homogenates under anaerobic conditions .

HY-B0165AR

Pravastatin sodium (Standard) 5+ Cited Publications CS-514 sodium (Standard)	Reference Standards HMG-CoA Reductase (HMGCR) Autophagy Ferroptosis	Cardiovascular Disease Cancer
Pravastatin (sodium) (Standard) is the analytical standard of Pravastatin (sodium). This product is intended for research and analytical applications. Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM.

HY-128033

Fenpropimorph	Environmental Pollutants Fungal	Infection
Fenpropimorph is a fungicide that inhibits the sterol pathway. Fenpropimorph inhibits δ8-δ7-sterol isomerase in yeast at low concentrations, with δ14-sterol reductase being blocked at higher levels, preventing the biosynthesis of ergosterol. Fenpropimorph also inhibits sterol synthesis in certain plants and mammalian cells .

HY-B0165

Pravastatin CS-514	Autophagy HMG-CoA Reductase (HMGCR)	Cardiovascular Disease Cancer
Pravastatin (CS-514) is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM .

HY-117089

Tetraconazole	Environmental Pollutants Fungal	Infection
Tetraconazole is a selective irreversible inhibitor of 14-α-sterol demethylase (CYP51) with antifungal activity. Tetraconazole competitively binds to the enzyme to block fungal ergosterol synthesis, resulting in cell membrane damage. The EC₅₀ of tetraconazole against wheat pathogens is 0.382-0.802 mg/L, and the EC₅₀ against onion root tip meristem cell growth is 6.7 mg/L, and (R)-(+)-Tetraconazole is 1.49-1.98 times more active than (S)-(-)-Tetraconazole. Tetraconazole can also induce oxidative stress and chromosomal aberrations in plant cells .

HY-N2221

Ganoderal A	Others	Metabolic Disease
Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor .

HY-121012

(rac)-AG-205	NF-κB Akt	Endocrinology
(rac)-AG-205 is a potent inhibitor of progesterone receptor membrane component 1 (Pgrmc1) that induces genes involved in sterol synthesis, including the INSIG1 protein, which forms a complex with PGRMC1. (rac)-AG-205 prevents neuronal resistance to hypoxic ischaemia by blocking NF-kB signalling and activation of the BDNF/PI3K/AKT pathway .

HY-B0165CS

Pravastatin-d3 sodium salt	Isotope-Labeled Compounds HMG-CoA Reductase (HMGCR) Autophagy	Cardiovascular Disease
Pravastatin-d₃ (sodium) is the deuterium labeled Pravastatin sodium salt. Pravastatin (CS-514) sodium salt is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM .

HY-114296S

2,3-Oxidosqualene-d6 Squalene oxide-d₆	Isotope-Labeled Compounds Drug Intermediate Endogenous Metabolite	Others
2,3-Oxidosqualene-d₆ (Squalene oxide-d₆) is a deuterium labeled 2,3-Oxidosqualene (HY-114296). 2,3-Oxidosqualene (Squalene oxide) is a sterol biosynthesis precursor intermediate.2,3-Oxidosqualene participates in cyclization pathways that form sterols and triterpenes, and contributes to introduction of their characteristic 3-hydroxyl group.2,3-Oxidosqualene forms metabolically from squalene in rat liver homogenates under sterol synthesis conditions.2,3-Oxidosqualene converts to sterols including cholesterol, lathosterol, and lanost-8-en-3β-ol in rat liver homogenates under anaerobic conditions.

HY-128033R

Fenpropimorph (Standard)	Fungal Reference Standards	Infection
Fenpropimorph (Standard) is the analytical standard of Fenpropimorph. This product is intended for research and analytical applications. Fenpropimorph is a fungicide that inhibits the sterol pathway. Fenpropimorph inhibits δ8-δ7-sterol isomerase in yeast at low concentrations, with δ14-sterol reductase being blocked at higher levels, preventing the biosynthesis of ergosterol. Fenpropimorph also inhibits sterol synthesis in certain plants and mammalian cells .

HY-117219

SKF 104976	Cytochrome P450 HMG-CoA Reductase (HMGCR) Endogenous Metabolite	Metabolic Disease
SKF 104976 is a 3,2-carboxylic acid derivative with potent 14-alpha-demethylase (14 alpha DM) inhibitory activity. SKF 104976 inhibited 14 alpha DM activity by 50% at 2 nM in Hep G2 cell extracts. SKF 104976 inhibited the incorporation of [14C]acetate into cholesterol in intact cells at similar concentrations, accompanied by accumulation of lanosterol, and resulted in a 40-70% decrease in 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) activity. SKF 104976 did not affect the uptake and degradation of low-density lipoprotein in Hep G2 cells, indicating that HMGR and low-density lipoprotein receptor activities are not coordinately regulated under these conditions. The inhibitory effect of SKF 104976 on HMGR activity remained unchanged even when the flux of carbon units in the sterol synthesis pathway was reduced by 80%. SKF 104976 did not inhibit HMGR activity under conditions where sterol synthesis was almost completely blocked by lovastatin .

HY-N7264R

7α-Hydroxycholesterol (Standard)	Reference Standards Others HMG-CoA Reductase (HMGCR) Toll-like Receptor (TLR) Akt Src ERK MDM-2/p53	Metabolic Disease Inflammation/Immunology
7α-Hydroxycholesterol is a cholesterol oxide and can serve as a biomarker for oxidative stress and lipid peroxidation. 7α-Hydroxycholesterol has cytotoxic and pro-inflammatory activities. 7α-Hydroxycholesterol can also inhibit sterol synthesis and reduce the activity of HMG-CoA reductase. 7α-Hydroxycholesterol can be used in the research of diseases such as diabetes and atherosclerosis .

HY-B1734

16-Dehydropregnenolone acetate 16-DPA	FXR 5 alpha Reductase Cytochrome P450 Drug Intermediate	Cardiovascular Disease Cancer
16-Dehydropregnenolone acetate (16-DPA), a sterols compound, is an orally active 17α-hydroxylase and 5α-reductase inhibitor. 16-Dehydropregnenolone is also a potent bile acid receptor (BAR)/farnesoid X receptor (FXR) antagonist. 16-Dehydropregnenolone hypolipidemic and anticancer effects. 16-Dehydropregnenolone acetate (16-DPA) is the drug intermediate that can be used for synthesis of Dexamethasone (HY-14648) and related other steroidal pharmacophores .

HY-130752

VNI	Cytochrome P450 Parasite	Infection
VNI is an effective inhibitor of CYP51. VNI can inhibit sterol synthesis in Trypanosoma cruzi, exhibiting anti-Trypanosoma cruzi activity .

HY-17396S

Butenafine-13C,d3 hydrochloride KP363-13C,d3 hydrochloride	Isotope-Labeled Compounds Fungal Antibiotic	Infection
Butenafine- ¹³C,d₃ (hydrochloride) is the ¹³C- and deuterium labeled. Butenafine Hydrochloride (KP363 Hydrochloride) is a synthetic benzylamine antifungal, works by inhibiting the synthesis of sterols by inhibiting squalene epoxidase.

HY-B0165AS

Pravastatin-13C,d3 sodium CS-514-13C,d3 sodium	Isotope-Labeled Compounds HMG-CoA Reductase (HMGCR) Autophagy Ferroptosis	Cardiovascular Disease Cancer
Pravastatin- ¹³C,d₃ (sodium) is the ¹³C- and deuterium labeled Pravastatin (sodium). Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.

HY-B0165S

Pravastatin-d9 sodium CS-514-d9 sodium	Autophagy HMG-CoA Reductase (HMGCR) Isotope-Labeled Compounds	Cardiovascular Disease Cancer
Pravastatin-d₉ sodium is deuterated labeled Pravastatin (HY-B0165). Pravastatin (CS-514) is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM .

HY-W749520

Zymosterone	Dihydrofolate reductase (DHFR)	Metabolic Disease
Zymosterone is converted into zymosterol, an intermediate in cholesterol synthesis, through the action of the enzyme hydroxysteroid (17β) dehydrogenase 7 (HSD17B7), and this transformation, catalyzed by 3-keto sterol reductase (ERG27), plays a crucial role in the biosynthesis of ergosterol in yeast.

HY-123457

PF-1163A	Fungal	Infection
PF-1163A is an antifungal agent that inhibits Ergosterol (HY-N0181) synthesis (IC₅₀ = 12 ng/mL), which is found in a fermentation broth of Penicillium sp. PF-1163A also inhibits *C-4 sterol* methyl oxidase with an MIC** value of 12.5 µg/mL .

HY-118843

Lombazole	Potassium Channel	Infection
Lombazole is an antimicrobial compound with activity that inhibits cell membrane synthesis. Lombazole had little effect on K+ permeability in S. aureus. Lombazole inhibited only de novo synthesis of cell enclosure in S. aureus, and this effect occurred before growth was affected. The main effect of lombazole was through inhibition of lipid synthesis. Lombazole may have an effect on key steps in lipid biosynthesis, as inferred from the lack of changes in lipid patterns after treatment. Lombazole also inhibited the sterol C-14 demethylation step in Candida albicans .

HY-W422288

(Rac)-Ketoconazole (Rac)-Ketoconazol; (Rac)-R 41400	Fungal Cytochrome P450	Infection
(Rac)-Ketoconazole ((Rac)-R 41400) is an antifungal imidazole compound with oral activity. (Rac)-Ketoconazole interferes with ergosterol synthesis by inhibiting cytochrome P450-dependent 14α-sterol demethylase (CYP51), a key enzyme on the fungal cell membrane, leading to membrane dysfunction and ultimately inhibition of fungal growth and reproduction. (Rac)-Ketoconazole is indicated for studies of fungal infections .

HY-119449

Florantyrone Zanchol	Others	Inflammation/Immunology
Florantyrone (Zanchol) is a bile-promoting agent. Florantyrone increases the volume of bile rather than the content of bile acids. Zanchol can stimulate the synthesis of cholesterol in the liver, significantly raising the plasma cholesterol level, increasing the weight of the liver, but has no significant effect on the synthesis of cholesterol in the intestine. Florantyrone can be used in research on biliary motility disorders .

HY-P2879D

Cholesterol esterase, Candida Rugosa	Biochemical Assay Reagents	Metabolic Disease
Cholesterol esterase, Candida Rugosa (EC 3.1.1.13), catalyzes the synthesis of sterols and fatty acids from sterol esters. In the presence of bile acids, it aggregates to form a hexamer, which may be the active form of this enzyme.

HY-137983

3-O-Acetylbetulin 3-Acetylbetulin	Drug Metabolite	Endocrinology
3-O-Acetylbetulin is a derivative of Betulin (HY-N0083), a sterol regulatory element-binding protein (SREBP) inhibitor. 3-O-Acetylbetulin can be utilized in synthesis of other betulin derivatives .

HY-16620

DF 461	Endogenous Metabolite	Metabolic Disease
DF 461 is a sterol synthase inhibitor with significant inhibitory activity. DF 461 shows high selectivity for the liver and can effectively inhibit cholesterol synthesis in rat liver. DF 461 has shown the effect of lowering plasma lipids in repeated dosing studies in non-rodents .

HY-125507

F81-1144b	MMP	Metabolic Disease
F81-1144b is a MMP-1 and MMP-3 inhibitor with IC₅₀ values of 5 nM and 29 nM, respectively. F81-1144b reduces serum and hepatic triacylglycerol levels, decreases the secretion of very-low-density lipoprotein-triacylglycerol, inhibits de novo hepatic fatty acid synthesis, and lowers serum insulin and glucose levels. F81-1144b can be used for the research of hypertriglyceridemia .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-B0165A

Pravastatin sodium Maximum Cited Publications 8 Publications Verification CS-514 sodium	Cardiovascular Disease Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Disease Research Fields Source Classification Cancer	HMG-CoA Reductase (HMGCR) Autophagy Ferroptosis
Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM.

HY-N7264

7α-Hydroxycholesterol 3 Publications Verification	Animals Classification of Application Fields Metabolic Disease Disease Research Fields Steroids Source Classification	HMG-CoA Reductase (HMGCR) Toll-like Receptor (TLR) Akt Src ERK MDM-2/p53
7α-Hydroxycholesterol is a cholesterol oxide and can serve as a biomarker for oxidative stress and lipid peroxidation. 7α-Hydroxycholesterol has cytotoxic and pro-inflammatory activities. 7α-Hydroxycholesterol can also inhibit sterol synthesis and reduce the activity of HMG-CoA reductase. 7α-Hydroxycholesterol can be used in the research of diseases such as diabetes and atherosclerosis .

HY-B0165AR

Pravastatin sodium (Standard) 5+ Cited Publications CS-514 sodium (Standard)	Cardiovascular Disease Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Disease Research Fields Source Classification Cancer	Reference Standards HMG-CoA Reductase (HMGCR) Autophagy Ferroptosis
Pravastatin (sodium) (Standard) is the analytical standard of Pravastatin (sodium). This product is intended for research and analytical applications. Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM.

HY-N2221

Ganoderal A	Triterpenes Classification of Application Fields Terpenoids Polyporaceae Metabolic Disease Ganoderma lucidum (Leyss. Ex Fr.) Karst. Plants Disease Research Fields Source Classification	Others
Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor .

HY-N7264R

7α-Hydroxycholesterol (Standard)	Structural Classification Animals Steroids Source Classification	Reference Standards Others HMG-CoA Reductase (HMGCR) Toll-like Receptor (TLR) Akt Src ERK MDM-2/p53
7α-Hydroxycholesterol is a cholesterol oxide and can serve as a biomarker for oxidative stress and lipid peroxidation. 7α-Hydroxycholesterol has cytotoxic and pro-inflammatory activities. 7α-Hydroxycholesterol can also inhibit sterol synthesis and reduce the activity of HMG-CoA reductase. 7α-Hydroxycholesterol can be used in the research of diseases such as diabetes and atherosclerosis .

Cat. No.	Product Name	Chemical Structure

HY-B0165CS

Pravastatin-d3 sodium salt
Pravastatin-d₃ (sodium) is the deuterium labeled Pravastatin sodium salt. Pravastatin (CS-514) sodium salt is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM .

HY-114296S

2,3-Oxidosqualene-d6
2,3-Oxidosqualene-d₆ (Squalene oxide-d₆) is a deuterium labeled 2,3-Oxidosqualene (HY-114296). 2,3-Oxidosqualene (Squalene oxide) is a sterol biosynthesis precursor intermediate.2,3-Oxidosqualene participates in cyclization pathways that form sterols and triterpenes, and contributes to introduction of their characteristic 3-hydroxyl group.2,3-Oxidosqualene forms metabolically from squalene in rat liver homogenates under sterol synthesis conditions.2,3-Oxidosqualene converts to sterols including cholesterol, lathosterol, and lanost-8-en-3β-ol in rat liver homogenates under anaerobic conditions.

2,3-Oxidosqualene-d6

2,3-Oxidosqualene-d₆ (Squalene oxide-d₆) is a deuterium labeled 2,3-Oxidosqualene (HY-114296). 2,3-Oxidosqualene (Squalene oxide) is a sterol biosynthesis precursor intermediate.2,3-Oxidosqualene participates in cyclization pathways that form sterols and triterpenes, and contributes to introduction of their characteristic 3-hydroxyl group.2,3-Oxidosqualene forms metabolically from squalene in rat liver homogenates under sterol synthesis conditions.2,3-Oxidosqualene converts to sterols including cholesterol, lathosterol, and lanost-8-en-3β-ol in rat liver homogenates under anaerobic conditions.

HY-17396S

Butenafine-13C,d3 hydrochloride
Butenafine- ¹³C,d₃ (hydrochloride) is the ¹³C- and deuterium labeled. Butenafine Hydrochloride (KP363 Hydrochloride) is a synthetic benzylamine antifungal, works by inhibiting the synthesis of sterols by inhibiting squalene epoxidase.

HY-B0165AS

Pravastatin-13C,d3 sodium
Pravastatin- ¹³C,d₃ (sodium) is the ¹³C- and deuterium labeled Pravastatin (sodium). Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.

HY-B0165S

Pravastatin-d9 sodium
Pravastatin-d₉ sodium is deuterated labeled Pravastatin (HY-B0165). Pravastatin (CS-514) is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC₅₀ of 5.6 μM .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

sterol synthesis

Inhibitors & Agonists

NaturalProducts

Isotope-Labeled Compounds

Natural
Products